Skip to main content
Top
Published in: Clinical and Experimental Nephrology 5/2018

01-10-2018 | Original article

Hypertension and its severity in children with steroid sensitive nephrotic syndrome during remission

Authors: Swasti Keshri, Shobha Sharma, Neha Agrawal, Sandeep Bansal, B. P. Guilliani, Kailash Chandra Aggrawal

Published in: Clinical and Experimental Nephrology | Issue 5/2018

Login to get access

Abstract

Background and objective

Hypertension is not a typical feature of steroid sensitive nephrotic syndrome (SSNS) and the presence of persistent hypertension is suggestive of significant renal lesion. There is paucity of data regarding occurrence and severity of hypertension in SSNS in pediatric population during remission and was the main objective of this study. In addition, correlation with factors like family history, BMI, and lipid profile was studied.

Methods

Cross-sectional study conducted at tertiary care center in India including 81 children of infrequent relapsing SSNS between 1 and 10 years in remission and was off steroids. Grading and severity of hypertension were assessed. Statistical analysis was done using SPSS version 21.0.

Results

Median age of presentation was 5 years, with male:female ratio of 1.3:1. Out of 81 infrequent relapsing SSNS children, 23.45% (19) had hypertension. Among those children with hypertension (n = 19), 73.68% (14) had positive family history compared to 32.25% (20) in those without hypertension. Positive correlation was found between BP and serum cholesterol and LDL. Of the hypertensive patients, 1 (5.26%) had fundus changes, 2 (10.52%) had features of left ventricular hypertrophy, and 13 (68.42%) had non-nephrotic range proteinuria.

Conclusion

There is high incidence of hypertension in NS children during remission. Though significant positive correlation was found with positive family history of hypertension and deranged lipid profile highlighting possibility of essential hypertension in them, there is need for close active monitoring and management of hypertension in them as untreated cases may have significant target organ damage.
Literature
1.
go back to reference Niaudet P, Boyer O. Idiopathic nephrotic syndrome in children: clinical aspects. In: Avner ED, harmon WE, Niaudet P, Yoshikawa N, Emma F, Goldstein SL, editors. Pediatric nephrology. Berlin: Springer; 2016. pp. 840. Niaudet P, Boyer O. Idiopathic nephrotic syndrome in children: clinical aspects. In: Avner ED, harmon WE, Niaudet P, Yoshikawa N, Emma F, Goldstein SL, editors. Pediatric nephrology. Berlin: Springer; 2016. pp. 840.
2.
go back to reference Bagga A, Srivastava RN. Nephrotic syndrome. In: Srivastava RN, Bagga A, editors. Pediatric nephrology. New Delhi: Jaypee Brothers medical Publishers (P) LTD; 2011. p. 195.CrossRef Bagga A, Srivastava RN. Nephrotic syndrome. In: Srivastava RN, Bagga A, editors. Pediatric nephrology. New Delhi: Jaypee Brothers medical Publishers (P) LTD; 2011. p. 195.CrossRef
3.
go back to reference Kliegman RM, Stanton BF, Geme JWS, Schor NF. Nelson textbook of pediatrics. 20th ed. In: Behrman RE, editors. Toronto: Elsevier; 2016. pp 2521–2527 Kliegman RM, Stanton BF, Geme JWS, Schor NF. Nelson textbook of pediatrics. 20th ed. In: Behrman RE, editors. Toronto: Elsevier; 2016. pp 2521–2527
4.
go back to reference Xu ZQ, Yi ZW, Dang XQ, Wu XC, He XJ. Relationship of 24-hour ambulatory blood pressure and rennin–angiotensin–aldosterone system in children with primary nephrotic syndrome. Zhongguo Dang Dai Er Ke Za Zhi. 2010;12(10):788–92.PubMed Xu ZQ, Yi ZW, Dang XQ, Wu XC, He XJ. Relationship of 24-hour ambulatory blood pressure and rennin–angiotensin–aldosterone system in children with primary nephrotic syndrome. Zhongguo Dang Dai Er Ke Za Zhi. 2010;12(10):788–92.PubMed
5.
go back to reference Xu ZQ, Yi ZW, Dang XQ, et al. Sympathetic nervous system level and ambulatory blood pressure in children with primary nephrotic syndrome. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2010;35(7):693–8.PubMed Xu ZQ, Yi ZW, Dang XQ, et al. Sympathetic nervous system level and ambulatory blood pressure in children with primary nephrotic syndrome. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2010;35(7):693–8.PubMed
6.
go back to reference Kontchou LM, Liccioli G, Pela I. Blood pressure in children with minimal change nephrotic syndrome during oedema and after steroid therapy: the influence of familial essential hypertension. Kidney Blood Press Res. 2009;32(4):258–62.CrossRefPubMed Kontchou LM, Liccioli G, Pela I. Blood pressure in children with minimal change nephrotic syndrome during oedema and after steroid therapy: the influence of familial essential hypertension. Kidney Blood Press Res. 2009;32(4):258–62.CrossRefPubMed
7.
go back to reference Küster S, Mehls O, Seidel C, Ritz E. Blood pressure in minimal change and other types of nephrotic syndrome. Am J Nephrol. 1990;10(Suppl 1):76–80.PubMed Küster S, Mehls O, Seidel C, Ritz E. Blood pressure in minimal change and other types of nephrotic syndrome. Am J Nephrol. 1990;10(Suppl 1):76–80.PubMed
8.
go back to reference Torres GAA, Kitsu MAA, Loza MJE, Keever MÁV. Cardiovascular risk factors in children with primary nephrotic syndrome. Rev Med Inst Mex Seguro Soc. 2015;53(Suppl 3):S284–93. (PubMed PMID: 26509304). Torres GAA, Kitsu MAA, Loza MJE, Keever MÁV. Cardiovascular risk factors in children with primary nephrotic syndrome. Rev Med Inst Mex Seguro Soc. 2015;53(Suppl 3):S284–93. (PubMed PMID: 26509304).
9.
go back to reference Gabban NI, Abdullah EA, Abdullah HN. Nephrotic syndrome and hypertension. Iraqi J Commun Med. 2010 (4);271–76. Gabban NI, Abdullah EA, Abdullah HN. Nephrotic syndrome and hypertension. Iraqi J Commun Med. 2010 (4);271–76.
10.
go back to reference Zsuzsanna A, Carmen D, Eva K, Zsigmond E, et al. Clinical features and histopathological spectrum in adolescent onset nephrotic syndrome in a Romanian Children Population. Acta Med Marisiensis. 2014;60(4):146–50.CrossRef Zsuzsanna A, Carmen D, Eva K, Zsigmond E, et al. Clinical features and histopathological spectrum in adolescent onset nephrotic syndrome in a Romanian Children Population. Acta Med Marisiensis. 2014;60(4):146–50.CrossRef
11.
go back to reference Paul VK, Bagga A. Ghai essential pediatrics. 8th ed. Chennai: CBS Publishers & Distributors Pvt Ltd; 2013. Paul VK, Bagga A. Ghai essential pediatrics. 8th ed. Chennai: CBS Publishers & Distributors Pvt Ltd; 2013.
13.
go back to reference Grosso A, Veglio F, Porta M, Grignolo FM, Wong TY. Hypertensive retinopathy revisited: some answers, more questions. Br J Ophthalmol. 2005;89:1646–54.CrossRefPubMedPubMedCentral Grosso A, Veglio F, Porta M, Grignolo FM, Wong TY. Hypertensive retinopathy revisited: some answers, more questions. Br J Ophthalmol. 2005;89:1646–54.CrossRefPubMedPubMedCentral
14.
go back to reference Khoury PR, Mitsnefes M, Daniels SR, Kimball TR. Age specific reference intervals for indexed left ventricular mass in children. J Am Soc Echocardiogr. 2009;22:709–14.CrossRefPubMed Khoury PR, Mitsnefes M, Daniels SR, Kimball TR. Age specific reference intervals for indexed left ventricular mass in children. J Am Soc Echocardiogr. 2009;22:709–14.CrossRefPubMed
15.
go back to reference Assadi F. Effect of microalbuminuria lowering on regression of left ventricular hypertrophy in children and adolescents with essential hypertension. Pediatr Cardiol. 2007;28:27–33.CrossRefPubMed Assadi F. Effect of microalbuminuria lowering on regression of left ventricular hypertrophy in children and adolescents with essential hypertension. Pediatr Cardiol. 2007;28:27–33.CrossRefPubMed
16.
go back to reference Seeman T, Pohl M, Palyzova D, John U. Microalbuminuria in children with primary and white-coat hypertension. Pediatr Nephrol. 2012;27:461–7.CrossRefPubMed Seeman T, Pohl M, Palyzova D, John U. Microalbuminuria in children with primary and white-coat hypertension. Pediatr Nephrol. 2012;27:461–7.CrossRefPubMed
17.
go back to reference Bloetzer C, Bovet P, Paccaud F, et al. Performance of targeted screening for the identification of hypertension in children. Blood Press. 2017;26(2):87–93.CrossRefPubMed Bloetzer C, Bovet P, Paccaud F, et al. Performance of targeted screening for the identification of hypertension in children. Blood Press. 2017;26(2):87–93.CrossRefPubMed
19.
go back to reference Haas GM, Bertsch T, Schwandr P. Prehypertension and cardiovascular risk factors in children and adolescents participating in the community-based prevention education program family heart study. Int J Prev Med. 2014;5(Suppl 1):S50–6.PubMedPubMedCentral Haas GM, Bertsch T, Schwandr P. Prehypertension and cardiovascular risk factors in children and adolescents participating in the community-based prevention education program family heart study. Int J Prev Med. 2014;5(Suppl 1):S50–6.PubMedPubMedCentral
20.
go back to reference Hong YM, Kang YJ. Suh S. Correlation between high blood pressure and lipid profile in children. Korean J Pediatr. 1995;38(12):1645–52. Hong YM, Kang YJ. Suh S. Correlation between high blood pressure and lipid profile in children. Korean J Pediatr. 1995;38(12):1645–52.
21.
go back to reference Dalili S, Mohammadi H, Rezvany SM, Dadashi A, Novin MH. The relationship between blood pressure, anthropometric indices and metabolic profile in adolescents: a cross sectional study. Indian J Pediatr. 2015;82(5):445–9.CrossRefPubMed Dalili S, Mohammadi H, Rezvany SM, Dadashi A, Novin MH. The relationship between blood pressure, anthropometric indices and metabolic profile in adolescents: a cross sectional study. Indian J Pediatr. 2015;82(5):445–9.CrossRefPubMed
22.
go back to reference Willaims KM, Shah AN, Morrison D, Sinha M. Demographic, clinical, and ophthalmoscopic findings from a 30 year british cohort. J Paediatr Ophthalmol Strabismus. 2013;50(4):222–8.CrossRef Willaims KM, Shah AN, Morrison D, Sinha M. Demographic, clinical, and ophthalmoscopic findings from a 30 year british cohort. J Paediatr Ophthalmol Strabismus. 2013;50(4):222–8.CrossRef
24.
go back to reference Hanevold C, Waller J, Daniels S, Portman R, Sorof J. The effects of obesity, gender, and ethnic group on left ventricular hypertrophy and geometry in hypertensive children: a collaborative study of the International Pediatric Hypertension Association. Pediatrics. 2004;113(2):328–33.CrossRefPubMed Hanevold C, Waller J, Daniels S, Portman R, Sorof J. The effects of obesity, gender, and ethnic group on left ventricular hypertrophy and geometry in hypertensive children: a collaborative study of the International Pediatric Hypertension Association. Pediatrics. 2004;113(2):328–33.CrossRefPubMed
27.
go back to reference Sorof JM1, Alexandrov AV, Cardwell G, Portman RJ. Carotid artery intimal–medial thickness and left ventricular hypertrophy in children with elevated blood pressure. Pediatrics. 2003;111(1):61–6.CrossRefPubMed Sorof JM1, Alexandrov AV, Cardwell G, Portman RJ. Carotid artery intimal–medial thickness and left ventricular hypertrophy in children with elevated blood pressure. Pediatrics. 2003;111(1):61–6.CrossRefPubMed
Metadata
Title
Hypertension and its severity in children with steroid sensitive nephrotic syndrome during remission
Authors
Swasti Keshri
Shobha Sharma
Neha Agrawal
Sandeep Bansal
B. P. Guilliani
Kailash Chandra Aggrawal
Publication date
01-10-2018
Publisher
Springer Singapore
Published in
Clinical and Experimental Nephrology / Issue 5/2018
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-018-1565-3

Other articles of this Issue 5/2018

Clinical and Experimental Nephrology 5/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.